{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-028809","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2025-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.237365+00:00","generated_at":"2026-05-16T12:25:39.367233+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Dr. Joyce transfers Village Oaks Pathology equity to Dr. Humphreys; new succession agreement executed","bullets":["Dr. Joyce (77) informed Company of desire to transfer 100% stock of Village Oaks Pathology to Dr. Humphreys; not due to disagreement.","On Dec 22, 2025, Village Oaks Pathology, PPLS, and Dr. Humphreys entered a Succession Agreement restricting disposal of equity.","Agreement provides for automatic transfer of equity to a successor upon death, disability, retirement, incompetence, or failure to meet eligibility requirements.","Dr. Humphreys must use commercially reasonable efforts to preserve Village Oaks Pathology's operations, contracts, and licenses."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-028809","json":"https://secwatch.observer/filing/0001493152-25-028809.json","markdown":"https://secwatch.observer/filing/0001493152-25-028809.md","text":"https://secwatch.observer/filing/0001493152-25-028809.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225028809/0001493152-25-028809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225028809/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:25:39.367233+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}